Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia.
about
The Fanconi anemia pathway and ubiquitinCurrent issues in anticoagulation.The role of ximelagatran in the treatment of venous thromboembolism.The ubiquitin system, disease, and drug discovery.Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling.Fanconi anaemia and leukaemia - clinical and molecular aspects.Scientific and clinical opportunities for modeling blood disorders with embryonic stem cellsNatural gene therapy in monozygotic twins with Fanconi anemiaPharmacogenetics of alkylator-associated acute myeloid leukemia.Fanconi anaemia genes and susceptibility to cancer.Hematopoietic changes during progression from Fanconi anemia into acute myeloid leukemia: case report and brief review of the literature.Leukemic survival factor SALL4 contributes to defective DNA damage repair.Maintenance of genome stability by Fanconi anemia proteins.Fanconi anaemia: from a monogenic disease to sporadic cancer.Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia.Polymorphic variations in the FANCA gene in high-risk non-BRCA1/2 breast cancer individuals from the French Canadian population.Recent advances in understanding hematopoiesis in Fanconi Anemia.Spectrum and significance of variants and mutations in the Fanconi anaemia group G gene in children with sporadic acute myeloid leukaemia.A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia
P2860
Q28756516-6CE74AE7-C109-43F2-AC2D-7C2E0F74CCD3Q33365707-C3344DA9-1AFE-4C22-B15E-187847029B80Q33369274-8EBE947C-EBCC-4AA0-818E-99DC259FEDD7Q33384295-DBE4246B-4032-4769-8AAC-A95C743745D8Q33647672-67924A57-7CA1-4742-93B4-6E39F2B0A6C1Q35828191-00CB1FB4-E4C2-4632-8435-592DF2797080Q35848553-854FB301-3D35-44C6-8339-67698C38F8DFQ35849565-11FCE010-15A2-438F-B414-59F9F834D2B0Q36555916-BB3A83FE-3B45-41C2-8A99-E2740482158AQ36602573-95F13F41-CB6E-4E75-AD01-579CD8BA4744Q36868596-4163D433-7F57-49DC-981D-AC25DAAAB72AQ37389409-B0C9518F-13DA-4613-B2D7-46273FD1D052Q37658498-0E0A7D21-216D-4C66-827D-1D96AC0C6A09Q37865169-52A0D20D-CC14-4989-BE42-98DA836DA693Q38449075-88C123C9-986C-4B49-8EEB-761A8211FEB3Q41133980-710498C9-D903-41EA-BEFE-4BCF9BB8CAA3Q48109237-AE491C65-45FF-4F2F-960B-AFEB1E69341AQ54605235-F54421DA-D593-4272-9977-4AC3F47FC816Q57943496-6B19E2FB-C8FC-4D2E-A2E1-3675D3855223
P2860
Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Acquired FANCA dysfunction and ...... lt acute myelogenous leukemia.
@en
type
label
Acquired FANCA dysfunction and ...... lt acute myelogenous leukemia.
@en
prefLabel
Acquired FANCA dysfunction and ...... lt acute myelogenous leukemia.
@en
P2093
P50
P1433
P1476
Acquired FANCA dysfunction and ...... ult acute myelogenous leukemia
@en
P2093
Carol A Reifsteck
Grover C Bagby
M William Lensch
Marc Tischkowitz
Michelle M Le Beau
Petra M Jakobs
S Ashley Speckhart
Shirley V Hodgson
Susan B Olson
Tracy A Christianson
P356
10.1182/BLOOD-2002-09-2781
P407
P577
2003-03-13T00:00:00Z